Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients with Relapsing-Remitting Multiple SclerosisJAMA 32:165-174,153, Burt, R.K.,et al, 2019